Insider Trading March 19, 2026

ContextLogic Director Buys $249,373 in Stock; Details of Holdings and Transaction Disclosed

Bobbili Raja purchased 29,000 shares on March 17 at $8.50-$8.75; current market price sits below the purchase range

By Caleb Monroe LOGC
ContextLogic Director Buys $249,373 in Stock; Details of Holdings and Transaction Disclosed
LOGC

ContextLogic Holdings director Bobbili Raja acquired 29,000 shares of the company's common stock on March 17 for a total of $249,373, at per-share prices between $8.50 and $8.75. The shares now trade at $8.03. Raja’s disclosed ownership includes 350,000 shares held directly via an estate planning vehicle and an additional 18,269,534 shares held indirectly. The company’s beta is reported at 2.21, and a market note flags significant price volatility.

Key Points

  • Director Bobbili Raja bought 29,000 shares of ContextLogic on March 17 for $249,373 at $8.50-$8.75 per share.
  • Following the purchase, Raja directly holds 350,000 shares via an estate planning vehicle and indirectly owns 18,269,534 shares.
  • The stock is trading at $8.03, below the director’s recent purchase prices; the company’s beta is reported at 2.21 and a market note flags significant volatility.

ContextLogic Holdings Inc (NASDAQ: LOGC) disclosed a director purchase in which Bobbili Raja bought 29,000 shares of the company's common stock on March 17. The total cost of the transaction was $249,373, with individual share prices recorded in a range from $8.50 to $8.75.

As of the latest reported quote, the company's stock is trading at $8.03, which is below the per-share prices at which Raja executed his purchase. The company is reported to carry a beta of 2.21. An InvestingPro tip included with the disclosure highlights that the stock has experienced notably volatile price movements.

The filing provides additional details about Raja's stake in the company. He directly owns 350,000 shares through an estate planning vehicle, and he also has indirect ownership of 18,269,534 shares. Those figures reflect the holdings disclosed alongside the recent open-market purchase.

For investors seeking more granular financial analysis, the disclosure points to a Pro Research Report on InvestingPro that includes further information about the company’s financial position and additional ProTips. The filing does not project future performance or provide guidance beyond the transaction and ownership figures listed.

Below are the transaction specifics as disclosed:

  • Shares purchased: 29,000
  • Total transaction value: $249,373
  • Purchase date: March 17
  • Price range: $8.50 to $8.75 per share
  • Current trading price (reported): $8.03
  • Reported company beta: 2.21

The filing does not include commentary on the director’s intent beyond the purchase, nor does it expand on plans for additional transactions. It limits itself to the raw transaction data and the holdings reported by Raja.


Investors who want a more comprehensive view of the company’s metrics and further analysis are directed to the referenced Pro Research Report and the additional ProTips available via InvestingPro.

Risks

  • Market price risk: The stock’s current trading price of $8.03 is below the $8.50-$8.75 range at which the director purchased shares, indicating potential near-term unrealized losses for that transaction.
  • Volatility risk: The company is reported to have a beta of 2.21 and a market note explicitly warns that price movements have been quite volatile, which can affect short-term valuation and trading activity.
  • Information limitations: The filing presents transaction and ownership details but does not include commentary on intent or future transactions, limiting clarity around the director’s longer-term plans.

More from Insider Trading

NextNav CEO Sells $190,794 in Stock Under Pre-Arranged 10b5-1 Plan; Company Highlights Liquidity After Q4 Mar 19, 2026 BCP Investment Director Sells $416K in Stock Amid Mixed Quarterly Results Mar 19, 2026 Klaviyo Director Executes $3.8M Sale, Converts Series A to Series B as Company Rolls Out $500M Buyback Mar 19, 2026 BFI Co. liquidates 19,980 Phibro Animal Health shares for about $1.19M under Rule 10b5-1 plan Mar 19, 2026 NextNav COO Sells $57K in Stock as Company Highlights Liquidity and PNT Progress Mar 19, 2026